Development and validation of a new algorithm for the reclassification of genetic variants identified in the BRCA1 and BRCA2 genes
- 2 August 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 147 (1), 119-132
- https://doi.org/10.1007/s10549-014-3065-9
Abstract
BRCA1 and BRCA2 sequencing analysis detects variants of uncertain clinical significance in approximately 2 % of patients undergoing clinical diagnostic testing in our laboratory. The reclassification of these variants into either a pathogenic or benign clinical interpretation is critical for improved patient management. We developed a statistical variant reclassification tool based on the premise that probands with disease-causing mutations are expected to have more severe personal and family histories than those having benign variants. The algorithm was validated using simulated variants based on approximately 145,000 probands, as well as 286 BRCA1 and 303 BRCA2 true variants. Positive and negative predictive values of ≥99 % were obtained for each gene. Although the history weighting algorithm was not designed to detect alleles of lower penetrance, analysis of the hypomorphic mutations c.5096G>A (p.Arg1699Gln; BRCA1) and c.7878G>C (p.Trp2626Cys; BRCA2) indicated that the history weighting algorithm is able to identify some lower penetrance alleles. The history weighting algorithm is a powerful tool that accurately assigns actionable clinical classifications to variants of uncertain clinical significance. While being developed for reclassification of BRCA1 and BRCA2 variants, the history weighting algorithm is expected to be applicable to other cancer- and non-cancer-related genes.Keywords
This publication has 46 references indexed in Scilit:
- A method and server for predicting damaging missense mutationsNature Methods, 2010
- BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implicationsCurrent Opinion in Obstetrics and Gynecology, 2010
- ACMG recommendations for standards for interpretation and reporting of sequence variations: Revisions 2007Genetics in Medicine, 2008
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesAmerican Journal of Human Genetics, 2007
- Analysis of missense variation in human BRCA1 in the context of interspecific sequence variationJournal of Medical Genetics, 2004
- Predicting Deleterious Amino Acid SubstitutionsGenome Research, 2001
- Prediction of deleterious human allelesHuman Molecular Genetics, 2001
- Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer casesBritish Journal of Cancer, 2000
- Risk models for familial ovarian and breast cancerGenetic Epidemiology, 2000
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994